Hidradenitis suppurativa in pediatric patients - 09/12/21
, Xue Ting Ooi, MBBS, MRCP, Nisha Suyien Chandran, MBBS, MRCPAbstract |
Interest in and research on hidradenitis suppurativa (HS) have increased during the past decade, resulting in expanded knowledge about associated comorbidities and treatment efficacy. Knowledge about pediatric-onset HS is still limited, based on case studies, small case series, and extrapolation from adult studies. With increasing prevalence of childhood obesity, decreasing pubertal age, and increasing awareness of HS, physicians may start encountering younger HS patients. This review presents an updated discussion on the epidemiology, pathophysiology, and associated comorbidities in HS, with a focus on pediatric and adolescent patients. It also suggests recommendations for investigation and treatment based on current evidence.
Le texte complet de cet article est disponible en PDF.Abbreviation used : HS, HbA1c
Plan
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
Vol 86 - N° 1
P. 140-147 - janvier 2022 Retour au numéro
Article précédent
- Surgical delays of less than 1 year in Mohs surgery associated with tumor growth in moderately- and poorly-differentiated squamous cell carcinomas but not lower-grade squamous cell carcinomas or basal cell carcinomas: A retrospective analysis
- Jack Lee, Vernon J. Forrester, Wendy M. Novicoff, Darren J. Guffey, Mark A. Russell
- Tyrosine kinase 2 and Janus kinase?signal transducer and activator of transcription signaling and inhibition in plaque psoriasis
- James G. Krueger, Iain B. McInnes, Andrew Blauvelt
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?